The triple type 2 signature confers more frequent exacerbations and worse mid-expiratory flow in moderate to severe asthma

Rory Chan (Lead / Corresponding author), Brian Lipworth

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
    27 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)2926-2928.e1
    Number of pages10
    JournalThe Journal of Allergy and Clinical Immunology: In Practice
    Issue number9
    Early online date26 May 2023
    Publication statusPublished - Sept 2023


    • eosinophil
    • fractional exhaled nitric oxide
    • allergy
    • asthma
    • exacerbations
    • type 2 inflammation
    • FEF25-75

    ASJC Scopus subject areas

    • Immunology and Allergy

    Cite this